1Katz-Brull R,Lavin PT,Lenkinski RE,et al.Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions.J Natl Cancer lnst,2002,94(6):1197
3Orel SG,Schnall MD.MR inaging of the breast for the detection,diagnosis,and staging of breast cancer.Radiology,2001,220(1):13
4Keicz F,Santyr GE,Cron GO,et al.Aplication of a quantitative modle to differentiate benign from malignant breast lesions detected by dynaic gadolinium-enhanced MRI.J Magn Reson Imaging,1996,6 (5):743
5Muller-Schimpfle M,Ohmenhauser K,Sand J,et al.Dynamic 3D-MR manmography:is there a benefit of sophisticated evaluation of enhancement curves for clinical routine? J Magn Reson Imaging,1997,7 (1):236
6Jacobs MA,Barker PB,Argani P,et al.Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging:a feasibility study.J Magn Reson Imaging,2005,21 (1):23
7He Q,Xu RZ,Shkarin P,et al.Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis,metabolic phenotyping,and characterization of tumor microenvironment.Dis Markers,2003-2004,19(2 -3):69
8Katz-Brull R,Seger D,Rivenson-segal D,et al.Metabolic markers of breast cancer:enhanced choline metabolism and reduced choline-ether phospholipid synthesis.Cancer Res,2002,62(7):1966
9Bakken I J,Axelson D,Kvistad KA,et al.Classification of in vivo ^1H MR spectra from breast tissue using artificial neural networks.Anticancer Res,2001,21(2B):1481
10Katz-Brull R,Margalit R,Degani H.Differential routing of choline in implanted breast cancer and normal organs.Magn Reson Med,2001,46(1):31
